SVICHER, VALENTINA

SVICHER, VALENTINA  

Dipartimento di Medicina Sperimentale  

Mostra records
Risultati 1 - 20 di 152 (tempo di esecuzione: 0.039 secondi).
Data di pubblicazione Titolo Autore(i) Tipo File
1-lug-2016 48 week outcomes of maraviroc-containing regimens following the genotypic or Trofile assay in HIV-1 failing subjects: the OSCAR Study Nozza, S; Pignataro, Ar; Galli, L; Svicher, V; Alteri, C; Boeri, E; Ripa, M; Castagna, A; Sampaolo, M; Clementi, M; Perno, Cf; Lazzarin, A Articolo su rivista
1-lug-2016 48 week outcomes of maraviroc-containing regimens following the genotypic or Trofile assay in HIV-1 failing subjects: the OSCAR Study Nozza, S; Pignataro, A; Galli, L; Svicher, V; Alteri, C; Boeri, E; Ripa, M; Castagna, A; Sampaolo, M; Clementi, M; Perno, Cf; Lazzarin, A Articolo su rivista
22-giu-2013 Anti-HBV treatment induces novel reverse transcriptase mutations with reflective effect on HBV S antigen Cento, V; Van Hemert, F; Neumann Fraune, M; Mirabelli, C; Di Maio, V; Salpini, R; Bertoli, A; Micheli, V; Gubertini, G; Romano, S; Visca, M; De Sanctis, G; Berkhout, B; Marino, N; Mazzotta, F; Cappiello, G; Spanò, A; Sarrecchia, C; CECCHERINI SILBERSTEIN, F; Andreoni, M; Angelico, M; Verheyen, J; Perno, Cf; Svicher, V Articolo su rivista
1-gen-2019 CCR5/CXCR4 dual antagonism for the improvement of HIV infection therapy Grande, F; Occhiuzzi, Ma; Rizzuti, B; Ioele, G; De Luca, M; Tucci, P; Svicher, V; Aquaro, S; Garofalo, A Articolo su rivista
1-ott-2007 Characterization and structural analysis of novel mutations in human immunodeficiency virus type 1 reverse transcriptase involved in the regulation of resistance to nonnucleoside inhibitors CECCHERINI SILBERSTEIN, F; Svicher, V; Sing, T; Artese, A; Santoro, M; Forbici, F; Bertoli, A; Alcaro, S; Palamara, G; d'Arminio Monforte, A; Balzarini, J; Antinori, A; Lengauer, T; Perno, Cf Articolo su rivista
1-gen-2011 Characterization of drug-resistance mutations in HBV D-genotype chronically infected patients, naïve to antiviral drugs. Salpini, R; Svicher, V; Cento, V; Gori, C; Bertoli, A; Scopelliti, F; Micheli, V; Cappiello, T; Spanò, A; Rizzardini, G; De Sanctis, G; Sarrecchia, C; Angelico, M; Perno, Cf Articolo su rivista
1-gen-2005 Characterization of novel HIV drug resistance mutations using clustering, multidimensional scaling and SVM-based feature ranking Sing, T; Svicher, V; Beerenwinkel, N; CECCHERINI SILBERSTEIN, F; Daumer, M; Kaiser, R; Walter, H; Korn, K; Hoffmann, D; Oette, M; Rockstroh, J; Fatkenheuer, G; Perno, Cf; Lengauer, T Intervento a convegno
1-gen-2009 Characterization of the patterns of drug-resistance mutations in newly diagnosed HIV-1 infected patients naive to the antiretroviral drugs Alteri, C; Svicher, V; Gori, C; D'Arrigo, R; Ciccozzi, M; CECCHERINI SILBERSTEIN, F; Selleri, M; Bardacci, S; Giuliani, M; Elia, P; Scognamiglio, P; Balzano, R; Orchi, N; Girardi, E; Perno, Cf; Capobianchi, M; De Carli, G; Galati, V; Grisetti, S; Navarra, A; Nicastri, E; Pittalis, S; Puro, V; Sampaolesi, A; Nurra, G; Selleri, M; Zaccarelli, M; Zaniratti, M; Di Carlo, A; Giuliani, M; De Filippis, A; Brancatella, R; Maggi, T; Gattari, P; Spizzichino, L; Schito, S; Sarmati, L; Battagin, G; Tacconi, L; Gallo, I; Anzalone, E; Pitorri, A; Caterini, A; Barbacci, S Articolo su rivista
1-gen-2016 Combined analysis of the prevalence of drug-resistant Hepatitis B virus in antiviral therapy-experienced patients in Europe (CAPRE) Hermans, L; Svicher, V; Pas, S; Salpini, R; Alvarez, M; Ben Ari, Z; Boland, G; Bruzzone, B; Coppola, N; Seguin Devaux, C; Dyda, T; Garcia, F; Kaiser, R; Kose, S; Krarup, H; Lazarevic, I; Lunar, M; Maylin, S; Micheli, V; Mor, O; Paraschiv, S; Paraskevis, D; Poljak, M; Puchhammer Stockl, E; Simon, F; Stanojevic, M; Stene Johansen, K; Tihic, N; Trimoulet, P; Verheyen, J; Vince, A; Weis, N; Yalcinkaya, T; Lepej, S; Perno, Cf; Boucher, C; Wensing, A Articolo su rivista
23-mag-2014 Comparative replication capacity of raltegravir-resistant strains and antiviral activity of the new-generation integrase inhibitor dolutegravir in human primary macrophages and lymphocytes Pollicita, M; Surdo, M; DI SANTO, F; Cortese, M; Fabeni, L; Fedele, V; Malet, I; Marcelin, A; Calvez, V; CECCHERINI SILBERSTEIN, F; Perno, Cf; Svicher, V Articolo su rivista
7-giu-2016 Complete hbv prophylaxis withdrawal in HBsAg-positive liver transplant recipients after long-term minimal immunosuppression Lenci, I; Baiocchi, L; Tariciotti, L; Di Paolo, D; Milana, M; Santopaolo, F; Manzia, T; Toti, L; Svicher, V; Tisone, G; Perno, Cf; Angelico, M Articolo su rivista
8-dic-2021 Crucial Role of Central Nervous System as a Viral Anatomical Compartment for HIV-1 Infection Borrajo, A; Svicher, V; Salpini, R; Pellegrino, M; Aquaro, S Articolo su rivista
1-gen-2020 Cryptic HBV replicative activity is frequently revealed in anti-HBC-positive/hbsag-negative patients with HIV infection by highly sensitive molecular assays, and can be predicted by integrating classical and novel serological HBV markers Salpini, R; Malagnino, V; Piermatteo, L; Mulas, T; Alkhatib, M; Scutari, R; Teti, E; Cerva, C; La Rosa, Ky; Brugneti, M; Bertoli, A; Rossi, B; Holzmayer, V; Gersch, J; Kuhns, M; Cloherty, G; Ceccherini-Silberstein, F; Perno, C-; Iannetta, M; Andreoni, M; Sarmati, L; Svicher, V Articolo su rivista
1-gen-2020 Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses Artese, A; Svicher, V; Costa, G; Salpini, R; Di Maio, Vc; Alkhatib, M; Ambrosio, Fa; Santoro, M; Assaraf, Yg; Alcaro, S; Ceccherini-Silberstein, F Articolo su rivista
1-gen-2020 Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses Artese, A; Svicher, V; Costa, G; Salpini, R; Di Maio, Vc; Alkhatib, M; Ambrosio, Fa; Santoro, M; Assaraf, Yg; Alcaro, S; Ceccherini Silberstein, F Articolo su rivista
1-gen-2018 The degree of HIV-1 amino acid variability is strictly related to different disease progression rates Scutari, R; Faieta, M; D'Arrigo, R; Fabeni, L; Mussini, C; Cossarizza, A; Casoli, C; Perno, Cf; Svicher, V; Alteri, C; Aquaro, S Articolo su rivista
1-gen-2013 Description of the L76V resistance protease mutation in HIV-1 B and "non-B" subtypes Charpentier, C; Lambert Niclot, S; Alteri, C; Storto, A; Flandre, P; Svicher, V; Perno, Cf; Brun Vézinet, F; Calvez, V; Marcelin, A; CECCHERINI SILBERSTEIN, F; Descamps, D Articolo su rivista
15-feb-2013 Detecting and understanding genetic and structural features in HIV-1 B subtype V3 underlying HIV-1 co-receptor usage Chen, M; Svicher, V; Artese, A; Costa, G; Alteri, C; Ortuso, F; Parrotta, L; Liu, Y; Liu, C; Perno, Cf; Alcaro, S; Zhang, J Articolo su rivista
1-set-2014 Detection of high levels of Survivin-immunoglobulin M immune complex in sera from hepatitis C virus infected patients with cirrhosis Matteucci, C; Sorrentino, R; Bellis, L; Ettorre, G; Svicher, V; Santoro, R; Vennarecci, G; Biasiolo, A; Pontisso, P; Scacciatelli, D; Beneduce, L; Sarrecchia, C; Casalino, P; Bernardini, S; Pierimarchi, P; Garaci, E; Puoti, C; Rasi, G Articolo su rivista
1-nov-2010 Different evolution of genotypic resistance profiles to emtricitabine versus lamivudine in tenofovir-containing regimens Svicher, V; Alteri, C; Artese, A; Forbici, F; Santoro, M; Schols, D; Van Laethem, K; Alcaro, S; Costa, G; Tommasi, C; Zaccarelli, M; Narciso, P; Antinori, A; CECCHERINI SILBERSTEIN, F; Balzarini, J; Perno, Cf Articolo su rivista